Gelonghui, January 16 | According to Reuters, a document submitted to the federal court in Delaware on Wednesday indicates that Gilead Sciences has reached a $1 billion settlement with the USA government regarding Gilead's HIV prevention drugs Truvada and Descovy. Previously, Gilead won a patent infringement lawsuit during a jury trial in 2023. Gilead's General Counsel Deborah Telman stated in a statement that the agreement allows "the company to continue focusing its resources on its mission to discover, develop, and provide innovative therapies to people with life-threatening diseases."
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
DeepSeek is gaining popularity, Global chip stocks are collectively declining, and NVIDIA dropped over 5% in night trading.
DeepSeek has taken a shot at Silicon Valley, ranking first in the free app download chart for Apple in the USA.
Market Alert | DeepSeek's explosive growth ignites AI Concept stocks, with MEITU rising over 20% and SenseTime increasing over 10%.
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
吉利德科学与美国政府就艾滋病药物达成10亿美元专利纠纷和解
Gilead Sciences reached a settlement with the USA government on a $1 billion patent dispute regarding AIDS drugs.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
1
Views 226
Write a comment
1
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report